TIME logo
Connect Wallet
Wallet Settings
Disconnect Wallet
MetaMask
WalletConnect
Sign In
My Account
Manage Account
Digital Magazines
Subscriber Benefits
TIME Storefront
Help Center
Sign Out
SUBSCRIBE FOR $19
Subscribe
Spotlight Story
Trump Is About to Stress Test Credibility of Judicial System
Close
My Account
Manage Account
Digital Magazines
Subscriber Benefits
TIME Storefront
Help Center
Sign Out
Sign In
Subscribe
Sections
Home
U.S.
Politics
World
Health
Climate
Future of Work by Charter
Business
Tech
Entertainment
Ideas
Science
History
Sports
Magazine
TIME 2030
TIME Studios
Video
TIME100 Talks
TIMEPieces
The TIME Vault
TIME for Health
TIME for Kids
TIME Edge
TIME CO2
Red Border: Branded Content by TIME
Join Us
Newsletters
Subscribe
Subscriber Benefits
Give a Gift
Shop the TIME Store
Connect Wallet
Customer Care
US & Canada
Global Help Center
Reach Out
Careers
Press Room
Contact the Editors
Media Kit
Reprints and Permissions
More
Privacy Policy
Your California Privacy Rights
Terms of Use
Site Map
Connect with Us
COVID-19
Presented By
Oura Ring Could Detect COVID-19 Before Symptoms
By Alice Park
Getting COVID-19 Can Weaken the Immune System
By Alice Park
Should You Take an Antiviral to Prevent Long COVID?
By Jamie Ducharme
Presidential Election Will Be a Battle Over Pandemic Memory
By Jacob Steere-Williams and Gavin Yamey
More in
COVID-19
China Approves Its First mRNA COVID Vaccine
A vaccine developed by local drugmaker CSPC Pharmaceutical Group Ltd. has been approved for emergency use, after the Chinese government held out on the mRNA shot co-developed by BioNTech SE and Pfizer Inc.
By Bloomberg
March 22, 2023
Scientists Found New Chinese Data Hinting at the Origin of COVID-19. Then It Was Deleted
DNA from raccoon dogs, which were sold in a Wuhan market, were found in close proximity to SARS-CoV-2 genetic material.
By Alice Park
March 17, 2023
The World Cannot Afford ‘Pandemic Fatigue’
Moving on would be a terrible mistake. This is the best time to start looking ahead to the next pandemic.
By Ellen Johnson Sirleaf
March 17, 2023
Paxlovid Moves Closer to Full FDA Approval
Pfizer’s COVID-19 pill won another vote of confidence from U.S. health advisers, clearing the way for FDA approval.
By Matthew Perrone/AP
March 16, 2023
Researchers Are Getting Closer to Learning How to Treat and Prevent Long COVID
Promising drugs include metformin and Paxlovid.
By Jamie Ducharme
March 16, 2023
Pfizer's Bivalent COVID-19 Booster Gets FDA Nod for Young Kids
Children ages six months to four years can get the booster at least two months after their primary series of shots.
By Nacha Cattan/Bloomberg
March 15, 2023
Decimated by COVID-19, A Texas County Struggles to Move On
Lamb County had one of the highest COVID-19 death rates in the nation. Amid tides of contradictory news and misinformation, many have little idea of who to blame.
By Alejandro De La Garza / Lamb County, Texas
March 15, 2023
America Needs a COVID-19 Bipartisan Commission to Prepare for the Next Pandemic
Without a postmortem on America's COVID-19 response we won't know how to respond better next time.
By Leslie Bienen and Margery Smelkinson
March 14, 2023
New York City Rats Carry COVID-19, Study Finds
They're able to be infected with the Alpha, Delta, and Omicron variants.
By Simmone Shah
March 10, 2023
People Are Far Less Likely to Get Long COVID After Omicron, Study Finds
The milder symptoms caused by Omicron variants may also reduce the chances of Long COVID.
By Alice Park
March 8, 2023
People with Long COVID Are at Higher Risk of Early Death and Disease
A new study finds that people with Long COVID are more likely to have heart and respiratory disease than people who did not get COVID-19.
By Jamie Ducharme
March 3, 2023
The U.K. Briefly Mulled Killing All Pet Cats to Stop COVID-19
Former U.K. deputy health minister Lord Bethell said it was considered early in the pandemic when little about the virus was known.
By Armani Syed
March 2, 2023
Why You Should Report Your Rapid Test Results
What makes at-home COVID-19 tests so convenient also makes them useless for health officials trying to keep tabs on the virus.
By Alice Park
March 1, 2023
Why We May Never Know COVID-19's Origin for Certain
Experts worry the charged atmosphere surrounding COVID's origin may keep us from ever knowing for sure whether the virus escaped a Chinese lab.
By Chad de Guzman
February 28, 2023
Why U.S. Experts Can't Agree on the Origins of COVID-19
The Energy Department concluded with a low level of confidence that COVID-19 most likely emerged as a result of a leak from a laboratory in China.
By Mini Racker
February 28, 2023
People Who Think They're Attractive Are Less Likely to Wear Masks, Study Says
"Mask-fishing" is real, researchers find.
By Jamie Ducharme
February 27, 2023
How the Post-Pandemic Cut on SNAP Benefits Will Affect Millions
Many families are expected to receive at least $95 less per month
By Solcyre Burga
February 26, 2023
You Can Now Test Yourself for Flu and COVID-19 At Home
The test from Lucira works in the same way as the at-home rapid antigen tests for COVID-19.
By Alice Park
February 24, 2023
COVID-19 Rebound Can Happen Even Without Paxlovid
New research provides more data for people weighing the risks and benefits of taking the antiviral drug Paxlovid for COVID-19.
By Alice Park
February 22, 2023
How COVID-19 Changes the Heart—Even After the Virus Is Gone
A study adds new evidence that SARS-CoV-2—the virus that causes COVID-19—could have a lasting impact on the heart.
By Alice Park
February 18, 2023
What's the Point of PCR Tests Anymore?
Experts say there are still times when a PCR test is useful.
By Jamie Ducharme
February 16, 2023
Omicron Can Raise the Risk of Diabetes, Study Says
Rates of newly diagnosed diabetes, high blood pressure, and elevated cholesterol were higher in the 90 days after COVID-19 infection.
By Tanaz Meghjani/Bloomberg
February 15, 2023
China’s Stunning Drop in COVID Deaths Revives Data Concerns
China is posting the steepest drop in Covid deaths among more than 20 places hit hardest by omicron, reviving questions about its virus data and the true impact of the reopening wave as Beijing works to move on from the pandemic.
By Jennifer Creery / Bloomberg
February 14, 2023
A One-Shot COVID-19 Treatment Shows Promise
The drug interferon lambda may represent a new generation of antiviral treatment. But it will likely be available overseas before the U.S.
By Alice Park
February 8, 2023
So, Is the Pandemic Over Yet?
Soon, COVID-19 will no longer be declared an emergency in the U.S. Here’s how public health experts feel about that path forward.
By Alice Park
February 8, 2023
We Still Don’t Know What Works Best to Slow the Spread Of COVID-19
Because of a lack of research, we still can’t answer important questions about what reduced the spread of COVID-19.
By Gideon Meyerowitz-Katz and Gavin Yamey
February 8, 2023
Stock Up on Free At-Home COVID-19 Tests While You Can
They may not be free for much longer.
By Jamie Ducharme
January 31, 2023
The U.S. COVID-19 Public Health Emergency Ends in May. Here’s What Will Change
The decision could affect tests, treatments, vaccines, and hospital care—and who pays for them.
By Alice Park
January 31, 2023
Without Evusheld, Immunocompromised People Are on Their Own Against COVID-19
'We've been forgotten and ignored.'
By Jamie Ducharme
January 31, 2023
The U.S. Still Doesn't Have Good COVID-19 Data. Here's Why That's a Problem
Data about COVID-19 hospitalizations and deaths are still incomplete. But we need them in order to start putting the pandemic behind us.
By Alice Park
January 30, 2023
COVID-19 Pandemic Will Be Over When Americans Think It Is
How will we know when the COVID-19 pandemic is over in the U.S.? Steven Phillips on how we have to think differently about risk today
By Steven Phillips
January 30, 2023
Evusheld Loses U.S. Authorization Since It's Not Effective Against New Variants
AstraZeneca's COVID-19 antibody drug, Evusheld, lost its authorization since it’s unlikely to work against current strains.
By Madison Muller/Bloomberg
January 27, 2023
FDA Experts Vote to Make All COVID-19 Vaccines and Boosters Bivalent
The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.
By Alice Park
January 26, 2023
The Bivalent Booster Protects Against New COVID-19 Variants, New Data Show
The data add to our understanding about how well Omicron shots can protect against newer COVID-19 variants, like BQ.1.1 and XBB.1.
By Alice Park
January 25, 2023
COVID-19 Is No Longer a Public Health Emergency
It's time to rethink the data we're using to measure the severity of the COVID-19 pandemic.
By Daniel Halperin
January 25, 2023
Moderna Says Its RSV Vaccine Works
Newly reported results from a late-stage human trial suggest Moderna's mRNA vaccine platform will work against another viral infection.
By Alice Park
January 18, 2023
China’s Lunar New Year Holiday Threatens a Grim Toll
The combination of millions of people crammed onto public transport traveling to a predominately elderly, under-vaccinated population in villages with rudimentary healthcare threatens to be a perfect storm.
By Charlie Campbell / Singapore
January 17, 2023
Hong Kong’s Leader Hopes to End Mask Mandate in 2023
The mask mandate is one of the only major curbs left remaining from the city’s COVID Zero days
By Felix Tam and Alfred Liu / Bloomberg
January 17, 2023
As COVID-19 Ravages China, Some Seek Black Market Drugs
Hong Kong customs officials seized over the weekend thousands of contraband antivirals headed for the mainland.
By Armani Syed
January 16, 2023
China’s True COVID Death Toll Estimated To Be in Hundreds of Thousands
China, which narrowed the definition of COVID mortality after it dismantled its zero tolerance approach, reported 60,000 deaths during its current outbreak.
By Bloomberg
January 16, 2023
Why Rapid COVID-19 Test Results Are Getting More Confusing
At-home COVID-19 test results can be hard to interpret
By Jamie Ducharme
January 12, 2023
Satellite Images Seem to Show China’s High COVID Death Toll
Photos show increased activity at funeral homes and crematoriums, as the virus surges throughout the country and reliable data is unavailable.
By Chad de Guzman
January 12, 2023
Many Long COVID Symptoms Resolve Within a Year, Study Suggests
At least among people who had mild COVID-19.
By Jamie Ducharme
January 11, 2023
Data Doesn’t Support New COVID-19 Booster Shots for Most, Says Expert
It’s time to rethink the blanket recommendation for giving the new Omicron booster to everyone
By Alice Park
January 11, 2023
Why the U.S. Nursing Shortage Keeps Getting Worse
Nurses are pushing for better staffing at New York City hospitals amid a nationwide uptick in COVID-19 cases.
By Tara Law
January 11, 2023
China Retaliates Against S. Korea, Japan Over COVID Restrictions
The moves represent China’s first attempt at retaliation after a raft of nations recently implemented testing requirements for travelers from the country
By Bloomberg
January 10, 2023
Load More Articles
More from
TIME
More From TIME
